CONMED | CNMD - 销售和管理费用



金融业
股票价格
USD
资产
USD 2.31B
现金及等价物
USD 40.82M
销售成本
USD 133.6M
流动资产
USD 670.59M
流动负债
USD 292.72M
债务
USD 834.94M
股息收益率
1.48
EBIT
USD 25.42M
EBITDA
USD 56.39M
员工
3.9K
EPS每股收益
USD 0.89
股本和储备
USD 1.02B
销售毛利
USD 183.45M
债务利息支出
USD 7.06M
贷款资金
USD 834.23M
市值
USD 1.27B
净收入
USD 13.83M
营业费用
USD 291.63M
营业利润
USD 25.42M
普通股股本
USD 30.97M
PE价格收益
9.39
税前利润
USD 29.25M
销售收入
USD 317M
销售和管理费用
USD 141.7M
股票
USD 366.11M
贸易债权人
USD 105.42M
应收帐款人
USD 247.83M


销售和管理费用 更改 日
3M USD 744M 221M 2026-03
Abbott USD 3.27B 138M 2026-03
Accuray USD 124.78M 2.54M 2025-12
AtriCure USD 84.55M 6.21M 2026-03
Avanos Medical USD 77.7M 1.1M 2026-03
Baxter International USD 728M 33M 2026-03
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Boston Scientific USD 1.78B 53M 2026-03
CONMED USD 141.7M 25.06M 2026-03
Cooper Companies USD 676.2M 303.1M 2026-03
Dexcom USD 349.7M 49.8M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 297.77M 20.7M 2026-03
Inogen USD 43.77M 510K 2024-06
Insulet USD 317.2M 14.2M 2026-03
Integra LifeSciences USD 178.24M 21.79M 2026-03
Intuitive Surgical USD 613.3M 73.8M 2026-03
J&J USD 6.03B 719M 2026-03
Medtronic 2.96B 9M 2025-12
Merit Medical Systems USD 110.47M 4.36M 2026-03
Olympus JPY 139.34B 13.69B 2026-03
Orthofix International USD 130.35M 11.31M 2025-12
ResMed USD 279.8M 1.4M 2026-03
Smith & Nephew USD 1.42B 65M 2025-12
Steris USD 351.8M 500K 2026-03
Stryker USD 2.15B 17M 2026-03
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 226.01M 3.64M 2026-03
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03